This inventor holds 35 USPTO granted patents, plus 6 CIPO patents, primarily in Antioxidant Agents. Top assignees: Merrell Dow Pharmaceuticals, Richardson-Merrell Inc., Hoechst Marion Roussel. Active years: 1976-2000.
Location History:
- Cinncinati, OH (US) (1997)
- Cincinnati, OH (US) (1976 - 2000)
Company Filing History:
15 out of 455 
13 out of 167 
6 out of 236 Years Active: 1976-2000
Areas of Expertise:
Title: Roger A. Parker: Innovator in Pharmaceutical Compounds
Introduction
Roger A. Parker, a prominent inventor based in Cincinnati, OH, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 35 patents. His innovative work primarily focuses on compounds with potential applications as antiatherosclerotic agents and antioxidants.
Latest Patents
Parker's latest patents include the invention of 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and its analogs, which are valuable in the fight against atherosclerosis. These compounds are not only unique in their chemical structure but also show promise as effective pharmaceutical agents. Another significant patent pertains to alkyl-4-silylheterocyclic phenols and thiophenols, which are formulated to provide antioxidant properties. The specificity of his inventions highlights the potential for new therapeutic applications.
Career Highlights
Throughout his career, Roger has made impactful contributions while working with reputable companies such as Merrell Dow Pharmaceuticals and Richardson-Merrell Inc. His role in these institutions has enhanced drug development processes, reflecting his commitment to advancing healthcare through innovative solutions.
Collaborations
Collaboration has been a key element in Parker's success. He has partnered with notable coworkers such as Simon J. Mao and Mark T. Yates, working together to push the boundaries of pharmaceutical research and development. These partnerships have enabled the exchange of ideas and facilitated the invention of several significant compounds.
Conclusion
Roger A. Parker's dedication to innovation in pharmaceuticals has positioned him as a leading inventor in his field. With a robust patent portfolio and impactful collaborations, he continues to contribute to advancements that may benefit public health and enhance treatment options for various diseases. His work serves as an inspiration to aspiring inventors and researchers alike.